Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Open accessThe DOI matches its Crossref record.
Abstract
Hum Reprod 2018;33:1602–1618 The journal, Human Reproduction, would like to apologise for an error under the sub-section Biochemical hyperandrogenism of Table III in the above article. The following statement: Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time. Should read: Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for 3 months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time. The electronic version of this article has been updated at https://doi.org/10.1093/humrep/dey256. The Journal would like to assure readers that this does not affect any other content of the article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Still being checked.
Cited by
Items 101–122 of 122
Babanrao, G. P. (2025) · A and V Pub International Journal of Nursing and Medical Research · doi:10.52711/ijnmr.2025.16
Liu, J., Huang, C., Jiao, J., Ma, Y., sun, Y., & Lan, C. (2025) · Research Square · doi:10.21203/rs.3.rs-6881341/v1 · Cited by 2
Dzwonkowska, A., & Redel, P. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3472
The Interaction between Psychological Factors and Polycystic Ovary Syndrome: A Systematic Review
赵, 淑. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1582358
Integrative Approach to PCOS: Pharmacological Insights from Siddha Formulations
Abarnadevika, A., Miruthunguptha, R. B., Aravindhan, N., & Ariharasivakumar, G. (2025) · doi:10.38124/ijisrt/25aug1216
What should be kept in mind when treating acne with oral contraceptives? Narrative review
Bakalczuk, P., Satora, M., Grunwald, A., Kułak, K., Brzuszkiewicz, K., & Bakalczuk, G. (2025) · Pielegniarstwo XXI wieku / Nursing in the 21st Century · doi:10.12923/pielxxiw-2025-0030
Polycystic ovary syndrome and cardiovascular disease risk
Друк, И. В., Друк, И. В., & Мамедов, М. Н. (2026) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2025-3183
Goyal, N., Sharma, S., Bhatia, R., & Gupta, S. (2026) · Current Drug Metabolism · doi:10.2174/0113892002424403251122104355
Tonato, E. A. J., Rea, A. M. C., Gavilanes, A. M. C., & Barahona, A. S. C. (2026) · Esprint Investigación · doi:10.61347/ei.v5i1.256 · Cited by 1
Le syndrome des ovaires polykystiques : quelles connaissances chez les médecins généralistes ?
Robert-Rambaud, P., Thubert, T., Fréour, T., & Chaillot, M. (2026) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2026.02.005
Abou‐El‐Naga, A. M., Elarby, N. Y., Sobh, M. A., & Mutawa, G. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103634
Neuregulin 4 improves white adipose tissue inflammation in mice with polycystic ovary syndrome
Wang, X., Feng, M., Hu, L., Li, X., Guo, S., Xue, H., & (38117), L. Z. (2026) · Peptides · doi:10.1016/j.peptides.2026.171496
Wu, C., Zhang, H., Cai, L., Lu, Y., Chen, H., & Luo, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1824366
Gordón, V., Monaco, M., Vergara, C., Samudio, R., & Luis, L. (2026) · Conducta Científica · doi:10.65050/rcc.v9n2a4
Wang, H., Su, C., Wei, J., Lu, W., Bi, T., Cheng, Q., & 纪冬梅 (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1894019
Liu, J., Huang, J., Teng, Z., Fu, Y., Tan, Y., Qin, Y., Chen, H., Liu, M., Chen, J., Wu, H., et al. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08540-w
Talukder, S., Saha, S., Fatema, K., Ahmed, N., & Begum, H. (2025) · TAJ Journal of Teachers Association · doi:10.70818/taj.v38i02.0846
Mazza, A. D. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.09.113
Khanom, K. A., Shetu, S. F., Ara, J., & Rahman, M. (2025) · TAJ Journal of Teachers Association · doi:10.70818/taj.v38i03.0949
Kadhim, W. A., Alawees, F. H. K., & Noori, A. A. E. K. (2026) · Clinical Medicine And Health Research Journal · doi:10.18535/cmhrj.v6i05.653
Ge, Z., Wang, J., & Zhang, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1978407
Metadata
- Authors
- Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & International PCOS Network
- Affiliations
- Monash Health (AU)
- UNSW Sydney (AU)
- University of Pennsylvania (US)
- Erasmus MC (NL)
- Oulu University Hospital (FI)
- National Health and Medical Research Council (AU)
- Corresponding author
- Teede, Helena J
- ORCID
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-06
- Volume
- 34
- Issue
- 2
- Pages
- 388-388
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- PMC
- PMC6343464
- OpenAlex
- W4248393160
- Cited by
- 120
- References
- 0
- Citations by year
- 2026: 18 · 2025: 15 · 2024: 15 · 2023: 19 · 2022: 8 · 2021: 16 · 2020: 19 · 2019: 9 · 2018: 1
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Reproduction (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- Monash University Research Portal (Monash University) (submittedVersion, cc-by-nc-nd)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- polycystic ovary syndrome, hormonal contraception, drug withdrawal, androgen measurement, non-hormonal contraception, evidence-based clinical guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.